secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001140361-23-034826
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology shareholders approve 2.4M share increase in equity plan, reelect directors
--------------------------------------------------------------------------------

- Stockholders approved Third Amended Restated 2014 Equity Plan, increasing authorized shares from 4,165,535 to 6,565,535.
- Elected Class B directors Kamil Ali-Jackson and Ilian Iliev; each received >5M votes for, 10M+ broker non-votes.
- Ratified KPMG as independent auditor for FY2023 with 17.2M votes for, 259K against.
- Non-binding advisory vote on executive compensation approved: 6.0M for, 1.4M against, 10.1M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/0001140361-23-034826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/brhc20055890_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-034826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer